Pallas Health vs TMates: Clinician Options and Pricing Compared
Pallas Health vs TMates: both sell clinically supervised compounded semaglutide, but they differ on medication options, pricing structure, and clinician access. Early verdict: choose Pallas Health if you want clinician choice between brand-name pens and compounded options with lower introductory compounded pricing. Choose TMates if you prefer a flat $199/month rate with 24/7 U.S. doctor access and nationwide licensing.
How they position care and medications
Pallas Health is 100% online and offers a clinician to select either FDA-approved brand-name GLP-1s such as Wegovy, Ozempic, Zepbound and Mounjaro or clinician-personalized compounded semaglutide and tirzepatide prepared in the USA when a brand medication is not the right fit. TMates focuses on clinically dosed compounded semaglutide formulated in U.S. facilities and does not advertise brand-name pens.
Five key differences at a glance
| Criteria | Pallas Health | TMates |
|---|---|---|
| Medication options | Brand-name Wegovy, Ozempic, Zepbound, Mounjaro or compounded semaglutide and tirzepatide | Compounded semaglutide clinically dosed; limited public detail on tirzepatide |
| Starting price | Compounded semaglutide $139 first month then $199/mo average | $199/month flat at every dose |
| Pricing model | Compounded plans priced by medication; intro month price then renews every 12 weeks | Flat monthly fee, same price at every dose, no step-up fees |
| Clinician access | Provider care included in plan price, asynchronous in most states; some states require video | 24/7 U.S. doctor access, licensed in all 50 states |
| Shipping and sourcing | Free expedited shipping; compounded in the USA | Free shipping; medications formulated in U.S.-based facilities |
Pricing and billing differences explained
Pallas Health advertises compounded semaglutide at $139 for the first month, then $597 every 12 weeks which averages $199 per month. Compounded tirzepatide starts at $179 first month then $897 per 12 weeks, a $299 per month average. Pallas notes that compounded plans are priced by medication rather than by milligram so titration does not raise the plan price and that brand-name options are cash-pay with published monthly cash prices.
TMates presents a flat $199 per month price at every dose with no step-up fees as dosage escalates. TMates lists multi month package pricing on its landing page but highlights the $199/month flat model and emphasizes budgeting stability for patients who want consistent monthly cost.
Clinician availability and state coverage
Pallas Health says a US licensed clinician reviews health history and personalizes the plan, with 100% online and asynchronous care in most states. A video visit is required in seven states plus Washington D.C. Care-team hours are weekdays 9 AM to 5 PM ET and no emergency services are offered. TMates claims 24/7 access to U.S.-based doctors and licensed coverage in all 50 states with virtual check-ins for oversight.
Compounded medication and regulatory notes
Both providers use compounded semaglutide and include the same regulatory caution: compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. Pallas states it does not manufacture or compound medication; compounded medications are prepared by U.S.-licensed compounding pharmacies and may differ in appearance from images. TMates states medications are formulated in U.S. facilities.
Support and plan inclusions
Pallas includes provider care, ongoing check-ins and care-team messaging in one all-in plan price with no membership fee, plus a self-serve portal and a free companion app. TMates emphasizes virtual check-ins and continuous physician availability, positioning clinical supervision as a primary benefit.
Comparison summary
Directly comparing Pallas Health vs TMates: Pallas offers a mix of brand-name and compounded options, a low introductory compounded month price and clinician-determined eligibility with asynchronous care in most states. TMates offers a single compounded semaglutide focus, a flat $199/month model with 24/7 U.S. doctor access and licensing across all 50 states. Both note compounded medications are not FDA approved.
Choose which provider if
Choose Pallas Health if you want a clinician who can select between FDA-approved brand-name pens and per-patient compounded preparations, prefer an intro compounded month from $139, want free expedited shipping and a plan price that includes provider care with no membership fee.
Choose TMates if you want flat $199/month pricing with no step-up fees, 24/7 access to U.S.-based doctors and licensing that covers all 50 states.
Both options require medical eligibility determined by a U.S. clinician and both use compounded medications that are not FDA approved.